Scientific Literature Search

Source record

Colonic LRRK2 expression is increased in Crohn's disease but not in Parkinson's disease and idiopathic RBD.

van der Haas J, Mantel M, Sellier-Montaigne L, de Guilhem de Lataillade A, Durand T, Oullier T, Le Berre C, Letournel F, Rolli-Derkinderen M, Leclair-Visonneau L, Derkinderen P.

Acta Neuropathol · 2026-09-19

DOI: 10.1007/s00401-026-03087-2PMID: 42762331

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Clinical and genetic findings in Parkinson's disease in a Turkish cohort: a retrospective exome sequencing study.

Canbek S, Gulseven MF, Mert G, Senol MG.

Neurogenetics · 2026-09-19

DOI: 10.1007/s10048-026-00943-xPMID: 42762359

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

GBA1 in Parkinson's disease: past, present and future.

Gan-Or Z.

Brain · 2026-09-18

DOI: 10.1093/brain/awag322PMID: 42758574

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Imaging nanoscopic co-assemblies of α-synuclein and Tau in human samples.

Zhang YP, Wallis A, Bertroli CO, Zhang C, Burke M, Layburn F, Lobanova E, Furlepa M, Kedia S, Cui Y, Suresh P, Yang WS, Quaegebeur A, Bartels T, Williams-Gray CH, Klenerman D.

Nat Commun · 2026-09-18

DOI: 10.1038/s41467-026-77728-1PMID: 42897149

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Genome-wide cross-trait analysis to compare genetic architecture between Parkinson's disease and kidney-related traits.

Chang L, Gawhary S, Maameri L, Belbellaj W, Lona-Durazo F, Gagliano Taliun SA.

Nat Commun · 2026-09-18

DOI: 10.1038/s41467-026-77920-3PMID: 42901928

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson's disease.

de Souza Júnyor F, Leser FS, de Souza Albuquerque S, de Barros-Telles R, Heimfarth L, da Silva Andrade B, Furtado CM, da Silva LF, Dos Santos FCP, de Oliveira ALSR, Ferreira ST, Braga C, da Fonseca CG, Neves GA, Romão L, Lima FRS.

Front Neurosci · 2026-09-17

DOI: 10.3389/fnins.2026.1913279PMID: 42824715

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.

Hu J, Elsaid S, Wu X, Ambye N, Tee SS.

Mol Neurobiol · 2026-09-16

DOI: 10.1007/s12035-026-06206-yPMID: 42747668

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson's Mice.

Yao L, Hatami M, Koc S, Jiang Q, Skutella T, Zhang Y.

Adv Sci (Weinh) · 2026-09-16

DOI: 10.1002/advs.202522066PMID: 42750142

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Fontana JC, Guimarães RL, de Faria AS, Braz KM, de Sá Pereira JF, Corrêa EM.

Parkinsonism Relat Disord · 2026-09-15

DOI: 10.1016/j.parkreldis.2026.108985PMID: 42743773

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson's disease.

Kazemi E.

Acta Neurol Belg · 2026-09-14

DOI: 10.1007/s13760-026-03194-7PMID: 42734894

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Correction: Ti et al. Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 6254.

Ti K, Zhao Y, Tan EK, Ma D.

Int J Mol Sci · 2026-09-14

DOI: 10.3390/ijms27188177PMID: 42794862

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Genetics of α-Synuclein: The Prime Pathological Player of Parkinson's Disease.

Sarhadi TR, Joshi N, Raveendran A, Panse JS, Nagotu S.

Neurotox Res · 2026-09-12

DOI: 10.1007/s12640-026-00827-wPMID: 42730873

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

9.897 articles found

Colonic LRRK2 expression is increased in Crohn's disease but not in Parkinson's disease and idiopathic RBD.

Clinical and genetic findings in Parkinson's disease in a Turkish cohort: a retrospective exome sequencing study.

GBA1 in Parkinson's disease: past, present and future.

Imaging nanoscopic co-assemblies of α-synuclein and Tau in human samples.

Genome-wide cross-trait analysis to compare genetic architecture between Parkinson's disease and kidney-related traits.

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson's disease.

TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.

Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson's Mice.

Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.

Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson's disease.

Correction: Ti et al. Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 6254.

Genetics of α-Synuclein: The Prime Pathological Player of Parkinson's Disease.

Filters